Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients

A number of human immunodeficiency virus type 1 (HIV-1) non-B-subtype products have been developed for present or future vaccine trials; in Thailand, several studies using subtype B and/or CRF01_AE vaccines have been conducted. To better characterize the biologic properties of these subtypes, 70 HIV...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Polonis, Victoria R., Souza, Mark S. de, Darden, Janice M., Chantakulkij, Somsak, Chuenchitra, Thippawan, Nitayaphan, Sorachai, Brown, Arthur E., Robb, Merlin L., Birx, Deborah L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2003
Sujets:
Pathogenesis and Immunity
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC165224/
https://ncbi.nlm.nih.gov/pubmed/12857927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.77.15.8570-8576.2003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires